Neuronal Signaling

Items 101-150 of 576

per page
Set Descending Direction
Catalog No.
Product Name
Application
Product Information
Product Citation
  1. Phenacetin is a non-opioid analgesic without anti-inflammatory properties.
  2. COX-2 inhibitor

    Rofecoxib (Vioxx) is a COX-2 inhibitor with IC50 of 18 nM.
  3. NMDA Receptor Antagonist

    TCN 201 is a NMDA receptor antagonist selective for NR1/NR2A over NR1/NR2B-containing receptors
  4. P2X1 antagonist

    NF279 is a suramin analog that acts as a highly selective, competitive, and reversible ATP-antagonist of P2X receptor (IC50/KB ~ 1 μM in smooth muscle).
  5. Methoctramine hydrate is a selective M2 muscarinic receptor antagonist at nM concentrations
  6. ATB-337 is a hybrid molecule of an H2S donor and the NSAID diclofenac
  7. Darifenacin works by blocking the M3 muscarinic acetylcholine receptor, which is primarily responsible for bladder muscle contractions.
  8. COX-1 inhibitor

    (-)-Epicatechin is a natural product from green tea. (-)Epicatechin is an inhibitor of Cox-1
  9. GABAA α5 receptor agonist

    MRK-016 is a selective, orally bioavailable inverse agonist of GABAA α5 receptor, with an EC50 of 3 nM for GABAA α5, and Kis of 0.83, 0.85, 0.77?and 1.4?nM for human?GABAA?α1β3γ2, GABAA?α2β3γ2, GABAA?α3β3γ2, and GABAA?α5β3γ2, respectively; MRK-016 also readily penetrates the CNS.
  10. COX-2 inhibitor

    Gallic acid is a trihydroxybenzoic acid found in many plants as either the free acid or in the esterified form of gallotannins and ellagitannins. Gallic acid is an antioxidant which can inhibit both COX-2.
  11. Jaceosidin is a pharmacologically active flavone derived from Artemisia argyi, inhibits phorbol-ester-induced upregulation of COX-2 and MMP-9 by blocking phosphorylation of ERK-1 and -2 in cultured human mammary epithelial cells.
  12. Catharanthine sulfate is a vinblastine-type alkaloid precursor with antitumor activity. It inhibits AChR by ion channel blocking and desensitization.
  13. BACE1 inhibitor

    BACE1-IN-1 is a potent and highly brain penetrant BACE1 inhibitor with IC50s of 32 and 47 nM for human BACE1 and BACE2, respectively.
  14. COX-1 inhibitor

    Catechin is a polyphenolic flavonoid which has been isolated from a variety of natural sources including tea leaves, grape seeds, and the wood and bark of trees such as acacia and mahogany.
  15. nAChR agonist

    (±)-Epibatidine is a nicotinic agonist. (±)-Epibatidine is a neuronal nAChR agonist.
  16. mAChR agonist

    AC260584 is an M1 muscarinic receptor allosteric agonist with a pEC50 of 7.6.
  17. BACE1 inhibitor

    Lanabecestat (AZD3293) is a potent, highly permeable, orally active and blood-brain barrier penetrating BACE1 inhibitor with a Ki of 0.4 nM.
  18. Bemegride is a central nervous system stimulant and antidote for barbiturate poisoning.
  19. muscarinic receptor inhibitor

    Darenzepine is a muscarinic receptor inhibitor extracted from patent US 20170095465 A1.
  20. acetylcholine receptor antagonist

    Beperidium iodide shows a competitive antagonistic effect against acetylcholine receptor with a pA2 of 7.93.
  21. Glucosylceramide synthase inhibitor

    Eliglustat is a specific and potent inhibitor of glucosylceramide synthase.
  22. P2X3 and P2X2/3 receptor antagonist

    A-317491 sodium salt hydrate is a non-nucleotide P2X3 and P2X2/3 receptor antagonist, which inhibits calcium flux mediated by the receptors.
  23. PKD inhibitor

    CID 2011756 is a protein kinase D (PKD) inhibitor (IC50 values are 0.6, 0.7 and 3.2 μM for PKD2, PKD3 and PKD1 respectively).
  24. PKD inhibitor

    kb NB 142-70 is a selective protein kinase D (PKD) inhibitor (IC50 values are 28.3, 58.7 and 53.2 nM for PKD1, 2 and 3 respectively).
  25. NMDA receptor antagonist

    SDZ 220-581 is a competitive NMDA receptor antagonist (pKi = 7.7).
  26. gamma-secretase modulator

    Flurizan is a nonsteroidal anti-inflammatory drug (NSAID) that inhibits γ-secretase activity.
  27. COX inhibitor

    (S)-(+)-Flurbiprofen is a non-selective Cox-1 and Cox-2 inhibitor.
  28. γ-secretase inhibitor

    BMS 299897 is an orally active, potent γ-secretase inhibitor (IC50 = 12 nM). Inhibits Aβ40 and Aβ42 formation in vitro (IC50 values are 7.4 and 7.9 nM respectively) and reduces Aβ in the brain, plasma and cerebrospinal fluid in vivo.
  29. AChE inhibitor

    Galanthamine is a potent acetylcholinesterase (AChE) inhibitor with an IC50 of 500 nM.
  30. COX inhibitor

    Meclofenamate Sodium is a dual COX-1/COX-2 inhibitor with IC50 of 40 nM and 50 nM.
  31. Benzodiazepine receptor agonist

    Pipequaline (PK 8165) is a partial benzodiazepine receptor agonist with anxiolytic activity.
  32. GABAA antagonist

    (+)-Bicuculline is a classical GABAA antagonist.
  33. P2X7 receptor antagonist

    A-438079 HCl is a competitive P2X7 receptor antagonist (pIC50 = 6.9 for the inhibition of Ca2+ influx in the human recombinant P2X7 cell line). Devoid of activity at other P2 receptors (IC50 >> 10 uM).
  34. Smilagenin (SMI) is a lipid-soluble small-molecule steroidal sapogenin from Rhizoma anemarrhenae and Radix asparagi widely used in traditional Chinese medicine for treating chronic neurodegeneration diseases.
  35. GABAA receptor antagonist

    Gabazine is a selective and competitive antagonist of GABAA receptor, with an IC50 of ~0.2 μM for GABA receptor.
  36. muscarinic antagonist

    Glycopyrrolate is a muscarinic competitive antagonist used as an antispasmodic.
  37. amyloid β42 inhibitor

    Ro 90-7501 is an inhibitor of amyloid β42 (Aβ42) fibril assembly; reduces Aβ42-induced toxicity (EC50 = 2 μM).
  38. Methyllycaconitine citrate is a potent antagonist for α7-containing neuronal nicotinic receptors (Ki = 1.4 nM). Interacts with α4β2 and α6β2 receptors at concentrations > 40 nM.
  39. Phenazepam is a benzodiazepine agonist of the ??-aminobutyric acid A (GABAA)-benzodiazepine receptor chloride channel complex.
  40. NMDA receptor agonist

    NMDA is a prototypic NMDA receptor agonist.
  41. NMDAR modulator

    GNE 0723 is a brain permeable positive allosteric modulator of NMDAR, with an EC50 of 21 nM for GluN2A, 7.4 and 6.2 μM for GluN2C and GluN2D, respectively.
  42. NMDA receptor antagonist

    (+)-MK 801 is a potent antagonist of NMDA with Ki value of 30.5nM.
  43. Miglustat hydrochloride is an orally active α-glucosidase I and II and ceramide-specific glycosyltransferase inhibitor.
  44. BACE1 inhibitor

    AZD3839 is a potent and selective inhibitor of human BACE1 with Ki of 26.1 nM.
  45. GABA transport inhibitor

    (S)-SNAP5114 is a selective GABA transport inhibitor, with IC50 values of 5 μM and 21 μM for hGAT-3 and rGAT-2, respectively. (S)-SNAP5114 is an anticonvulsant drug.
  46. M1 receptor modulator

    MK7622 is a muscarinic M1 receptor positive allosteric modulator.
  47. partial agonist of GABA(A) receptor

    RWJ-51204 is a partial agonist of GABA(A) receptor, with Ki of 0.2-2 nM to the benzodiazepine site on GABA(A) receptors.
  48. COX/5-LOX inhibitor

    Tepoxalin is a dual cyclooxygenase/5-lipoxygenase inhibitor of arachidonic acid metabolism with potent anti-inflammatory activity and a favorable gastrointestinal profile
  49. muscarinic AChR antagonist

    Flavoxate binds and inhibits muscarinic receptors, thereby suppressing the micturition reflex and increases urinary bladder capacity by modifying the micturition center in the brain stem.
  50. NMDA antagonist

    Eliprodil is a non-competitive NR2B-NMDA receptor antagonist(IC50=1 uM), less potent for NR2A- and NR2C-containing receptors(IC50> 100 uM).

Items 101-150 of 576

per page
Set Descending Direction